TKI Clinical Trials

3 actively recruiting trials

▲ +1 trial since July 2026

Also known as: Cohort 5 (ACC-TKI)

Pipeline

Phase 2: 2Phase 1/2: 1

Top Sponsors

Tata Memorial Hospital1
Peking Union Medical College1
Lepu Biopharma Co., Ltd.1

Indications

Cancer3
Liver Disease1
Driver Mutation1
Precision Therapy1
Oligometastatic Disease1

Other3 trials

Local Consolidative Radiation Therapy Plus TKI Versus TKI Alone in Driver Mutated OM-NSCLC

Phase 2

MRG006A Combination Therapy for Advanced Hepatocellular Carcinoma (Phase I/II)

Phase 1/2

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular Typing

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.